Comparison between clarithromycin and levofloxacin in treatment of H pylori

Levofloxacin-based versus Clarithromycin-based triple therapy for Treatment of Helicobacter pylori

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202012742050337

Enrollment

200

Registered

2020-12-07

Start date

2020-12-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Helicobacter pylori

Interventions

Levofloxacin plus amoxycillin plus esomeprazol

Clarithromycine plus Amoxicillin plus Esomeprazol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age group: = 18 year. Treatment-naiive patients. Positive H pylori stool antigen or histopathology.

Exclusion criteria

Exclusion criteria: Previous experience of treatment of H pylori. Known allergy to any of the medication used

Design outcomes

Primary

Measure	Time frame
Cure confirmed by negative H pylori stool antigen	—

Secondary

Measure	Time frame
Safety by measuring side effects	—

Countries

Egypt

Contacts

Public ContactSamer Fathy

Department Secretary

samerfathi2012@gmail.com00201065264003

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026